David P. Ryan
Medical and Scientific Advisor @ MPM Capital
San Francisco Bay Area, United States
David P. Ryan is a funding round investor at MPM Capital in San Francisco Bay Area focused on Big Data and Computer. David P. Ryan M.D., a standing member of OIF’s MSAB, is Chief of Hematology/Oncology, Massachusetts General Hospital Cancer Center, the Clinical Director of the Mass General Cancer Center, and an Associate Professor of Medicine, Harvard Medical School.David undertook his hematology and oncology training at the combined MassachusettsGeneral Hospital/Dana Farber Cancer Institute in 1996 in Boston, MA. In 1998, he was appointed Clinical Assistant in Medicine at the Massachusetts General Hospital, then Assistant in Medicine. The principal focus of David’s clinical research is the design and implementation of Phases I and II trials in gastrointestinal malignancies. Since 1998 he has been a member of both the Experimental Therapeutics Group and the Gastrointestinal Cancer Center where he has been the Clinical Director since 2003. In 2009, he became the Clinical Director of the MGH Cancer Center and in 2012, became Chief of the MGH Cancer Center.David’s clinical practice focuses exclusively on gastrointestinal oncology.He graduated in medicine from Columbia College of Physicians and Surgeons, New York, NY in 1992 where he remained for his internship and medical residency. He is a member of the American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO) and the New England Cancer Society. David sits on the editorial board of Clinical Cancer Research and The Oncologist. He has published over 100 articles in peer review journals, reviews, book chapters and editorials.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries David P. Ryan invests in
Stages David P. Ryan invests in
Countries David P. Ryan invests in
Investment Focus
Industry
- Big Data 1 (100%)
- Computer 1 (100%)
- Security 1 (100%)
- Software 1 (100%)
- Smart Home 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Aerial
|
Aerial's technology leverages existing infrastructure to recognize activity without the need for cameras, sensors or wearables. Aerial's patented technology analyzes distortions and fluctuations in the existing wireless signals and uses AI to interpret them and classify human activities. | $3M / Nov 08, 2018 |
Co-Investors
About MPM Capital
MPM Capital is a healthcare investment firm that invests in companies developing therapeutic technologies in oncology. The company invests in life sciences companies that seek to cure diseases by translating science into clinical outcomes. The company prefers to invest in the biotechnology, healthcare, and life sciences sectors.
MPM Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
David P. Ryan
Medical and Scientific Advisor
|
|||
Detlev Biniszkiewicz
Executive Partner
|
|||
Uciane Scarlett
Principal
|
|||
Ansbert Gadicke
Managing Director and Co-Founder
|
|||
Bard Geesaman
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does David P. Ryan invest in?
David P. Ryan invests primarily in Big Data, Computer and Security startups, most often at Funding Round stage. Most of the 1 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did David P. Ryan last invest?
The most recent investment recorded for David P. Ryan closed in Nov 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
